Literature DB >> 17716299

Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance.

N A Crimmins1, L J Martin.   

Abstract

Adiponectin plays an important role in insulin sensitivity via adiponectin receptor 1 and 2 signalling. To date, six genetic association studies have examined the role of polymorphisms in the adiponectin receptor 1 and 2 genes (ADIPOR1 and ADIPOR2) in insulin resistance and type 2 diabetes. These studies are summarized in this review along with unpublished data from the authors. In addition, these polymorphism studies are used to illustrate some of the potential pitfalls and reasons for poor reproducibility of findings in genetic association studies.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17716299     DOI： 10.1111/j.1467-789X.2007.00348.x

Source DB:  PubMed          Journal:  Obes Rev        ISSN： 1467-7881            Impact factor:   9.213


  18 in total

Review 1.  Adipokines and insulin resistance.

Authors:  Katja Rabe; Michael Lehrke; Klaus G Parhofer; Uli C Broedl
Journal:  Mol Med       Date:  2008-09-17       Impact factor: 6.354

Review 2.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

3.  The effect of resveratrol on the expression of AdipoR1 in kidneys of diabetic nephropathy.

Authors:  Hongfei Ji; Lina Wu; Xiaokun Ma; Xiaojun Ma; Guijun Qin
Journal:  Mol Biol Rep       Date:  2014-01-12       Impact factor: 2.316

4.  Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women's Health Initiative.

Authors:  Virginia G Kaklamani; Thomas J Hoffmann; Timothy A Thornton; Geoffrey Hayes; Rowan Chlebowski; Linda Van Horn; Christos Mantzoros
Journal:  Breast Cancer Res Treat       Date:  2013-04-30       Impact factor: 4.872

5.  Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer.

Authors:  Preet K Dhillon; Kathryn L Penney; Fredrick Schumacher; Jennifer R Rider; Howard D Sesso; Michael Pollak; Michelangelo Fiorentino; Stephen Finn; Massimo Loda; Nader Rifai; Lorelei A Mucci; Edward Giovannucci; Meir J Stampfer; Jing Ma
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-29       Impact factor: 4.254

6.  Gene-Environment Interactions and the Risk of Barrett's Esophagus in Three US Cohorts.

Authors:  Marta Crous-Bou; Manol Jovani; Immaculata De Vivo; Brian C Jacobson
Journal:  Am J Gastroenterol       Date:  2019-06       Impact factor: 10.864

7.  Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk.

Authors:  Virginia Kaklamani; Nengjun Yi; Kui Zhang; Maureen Sadim; Kenneth Offit; Carole Oddoux; Harry Ostrer; Christos Mantzoros; Boris Pasche
Journal:  Metabolism       Date:  2011-03-12       Impact factor: 8.694

8.  Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk.

Authors:  Virginia G Kaklamani; Maureen Sadim; Alex Hsi; Kenneth Offit; Carole Oddoux; Harry Ostrer; Habibul Ahsan; Boris Pasche; Christos Mantzoros
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

9.  Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk.

Authors:  Virginia G Kaklamani; Kari B Wisinski; Maureen Sadim; Cassandra Gulden; Albert Do; Kenneth Offit; John A Baron; Habibul Ahsan; Christos Mantzoros; Boris Pasche
Journal:  JAMA       Date:  2008-10-01       Impact factor: 56.272

Review 10.  Molecular pathways: adiponectin and leptin signaling in cancer.

Authors:  Michael N Vansaun
Journal:  Clin Cancer Res       Date:  2013-01-25       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.